Skip to main content
. 2015 Jul 31;36(6):503–509. doi: 10.1177/0333102415597891

Figure 1.

Figure 1.

Main efficacy measure. Mean cluster attack frequency per week for baseline and after one single BTA treatment of SPG, intention-to-treat analysis (n = 9).

BTA: onabotulinumtoxinA; SPG: sphenopalatine ganglion.